Growth Metrics

Nexalin Technology (NXL) EPS (Weighted Average and Diluted) (2022 - 2025)

Nexalin Technology (NXL) has 4 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.13 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 43.48% year-over-year to -$0.13; the TTM value through Sep 2025 reached -$0.67, down 4.69%, while the annual FY2024 figure was -$0.83, 31.75% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.13 in Q3 2025 per NXL's latest filing, down from -$0.1 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.02 in Q3 2022 and bottomed at -$0.31 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.15, with a median of -$0.12 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 1450.0% in 2023, then soared 43.48% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.11 in 2022, then grew by 9.09% to -$0.1 in 2023, then plummeted by 190.0% to -$0.29 in 2024, then surged by 55.17% to -$0.13 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.13 in Q3 2025, -$0.1 in Q2 2025, and -$0.15 in Q1 2025.